A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a potential new treatment target for patients with ...
A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...
Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...
The Advertising Standards Authority (ASA) has prohibited advertisements for prostate supplements and home testing kits, fearing they could mislead vulnerable individuals or deter them from appropriate ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
University of Westminster provides funding as a member of The Conversation UK. A roster of high profile advocates, including sportsmen, actors, two previous prime ministers and over 100 MPs, have ...
A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...
“Grey’s Anatomy” actor James Pickens Jr. saves lives on screen, but says early detection saved his. The actor, who has portrayed Dr. Richard Webber on the ABC hit for more than 20 years, appeared in ...
As interdisciplinary collaborators at Wayne State University, the School of Medicine’s Sheryl Roberts, Ph.D., left, and College of Liberal Arts and Sciences’ Christopher Kelly, Ph.D., are advancing ...
Stage 2 prostate adenocarcinoma is localized, with a nearly 100% five-year relative survival rate. Diagnosis uses the TNM system, PSA levels, and Gleason score to determine cancer stage and risk.
The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...
Approaches to early detection of cancer often seem contentious, but the big-picture view is actually one of remarkable consensus. All major guideline groups recommend the Papanicolaou smear, ...